BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

April 12, 2000

View Archived Issues

Atlantic submits IND for CT-3 to FDA; phase I trials to commence in France

Read More

Amarillo Biosciences reports phase III results for interferon alfa in Sjogren's syndrome

Read More

Celgene awarded patent for drug distribution system

Read More

Proof of concept demonstrated for PPL's transgenic BSSL

Read More

Clinical hold placed on South African study of Coviracil

Read More

Memantine improves cognition in vascular dementia patients

Read More

SangCya approved in Germany

Read More

Magainin discovers additional aminosterols with therapeutic potential

Read More

CV Therapeutics receives milestone from Biogen

Read More

Potential new diagnostic for AD presented by Axonyx

Read More

Periodontix's histatin mouthrinse reduces plaque and gingivitis

Read More

L-Arginine prevents chronic ciclosporin-induced renal dysfunction in heart transplant recipients

Read More

Canine studies demonstrate efficacy of NIP-142 in atrial flutter

Read More

Deleterious effects reported for ET antagonist immediately following MI in rat model

Read More

Japanese investigators explore uses for new chymase inhibitor SUN-C8257

Read More

NU-3108: profile of a novel nucleoside transport inhibitor

Read More

Small-molecule AICARFT inhibitors in the pipeline at Agouron

Read More

New benzodiazepinone derivatives under study at Aventis as inhibitors of bone resorption

Read More

Pfizer's new opioid receptor ligands claimed for use in painful, inflammatory and other disorders

Read More

Roche describes new ligands for the opioid-like receptor OFQ with a piperidine structure

Read More

Novel dihydrobenzopyrans exert both antiarrhythmic and antifibrillatory activities

Read More

Potent inhibition of human PDE4 reported for new Kyowa Hakko compound

Read More

Antitumor activity and pharmacokinetics of new taxoid TXD-258 discussed at ACS meeting

Read More

Aradigm announces gene therapy research collaboration with UCSF

Read More

New ocular antibiotic enters the pipeline at InSite Vision

Read More

Servier succeeds in improving antitumor activity of acronycine with S-23906-1

Read More

AVI-4126, a novel antisense compound; preclinical data presented recently support phase I/II trials

Read More

Keppra receives Swiss approval for treatment of epilepsy

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 9, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing